International Patent: 1 H-BENZO[D]IMIDAZOLE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE

GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055730) for “1 H-BENZO[D]IMIDAZOLE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE”. With publication no. WO/2026/107421, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....